Filing of the 2023 Universal Registration Document, containing the Annual Financial Report, and the American “Form 20-F”
Paris, February 23, 2024
. Sanofi announces that it has filed its 2023 Universal Registration Document containing the Annual Financial Report with the Financial Markets Authority (AMF) in France and its “Form 20-F” with the Securities and Exchange Commission (SEC) in UNITED STATES.
The report of the Board of Directors on corporate governance as well as the report of the auditors relating thereto; information relating to fees paid to auditors; information relating to the share buyback program; and information relating to social, environmental and societal responsibility (including the extra-financial performance declaration and the vigilance plan) also appears in the 2023 Universal Registration Document.
The documents can be consulted on the company’s website: https://www.sanofi.com/fr/investors/rapports-et-publications/rapports-financiers-et-information-reglementee
The Universal Registration Document is also available on the AMF website (www.amf-france.org) and the “Form 20-F” on the SEC website (www.sec.gov). A printed version of these documents containing the audited financial statements can be obtained upon request and free of charge.
About Sanofi
We are an innovative, global health company driven by a purpose: pursuing the miracles of science to improve people’s lives. Our teams, present in around a hundred countries, are working to transform the practice of medicine to make the impossible possible. We provide therapeutic solutions that can change the lives of patients and vaccines that protect millions of people around the world, guided by the ambition of sustainable development and our social responsibility.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY
Media relations
Sandrine Guendoul
| + 33 6 25 09 14 25 |
Nicolas Obrist
| + 33 6 77 21 27 55 |
Investor relations
Eva Schaefer-Jansen
| + 33 7 86 80 56 39 | [email protected]
Arnaud Delépine
| + 33 6 73 69 36 93 | [email protected]
Corentine Driancourt
| + 33 6 40 56 92 21 | [email protected]
Felix Lauscher
| +1 908 612 7239 | [email protected]
Tarik Elgoutni
| +1 617 710 3587 | [email protected]
Nathalie Pham
| + 33 7 85 93 30 17 | [email protected]
Attachment